ORIX - SPONSORED ADR (IX) Fundamental Analysis & Valuation

NYSE:IX • US6863301015

Current stock price

29.8 USD
-0.23 (-0.77%)
At close:
29.8 USD
0 (0%)
After Hours:

This IX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. IX Profitability Analysis

1.1 Basic Checks

  • In the past year IX was profitable.
  • In the past year IX had a positive cash flow from operations.
  • Each year in the past 5 years IX has been profitable.
  • IX had a positive operating cash flow in each of the past 5 years.
IX Yearly Net Income VS EBIT VS OCF VS FCFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B 1T

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.50%, IX is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
  • The Return On Equity of IX (9.90%) is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 3.15%, IX perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for IX is significantly below the industry average of 8.10%.
  • The last Return On Invested Capital (3.15%) for IX is above the 3 year average (2.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.5%
ROE 9.9%
ROIC 3.15%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
IX Yearly ROA, ROE, ROICIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • IX has a better Profit Margin (14.49%) than 62.00% of its industry peers.
  • IX's Profit Margin has declined in the last couple of years.
  • IX has a Operating Margin of 19.97%. This is in the better half of the industry: IX outperforms 69.00% of its industry peers.
  • IX's Operating Margin has been stable in the last couple of years.
  • IX has a better Gross Margin (42.41%) than 64.00% of its industry peers.
  • In the last couple of years the Gross Margin of IX has grown nicely.
Industry RankSector Rank
OM 19.97%
PM (TTM) 14.49%
GM 42.41%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
IX Yearly Profit, Operating, Gross MarginsIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. IX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IX is destroying value.
  • Compared to 1 year ago, IX has less shares outstanding
  • IX has less shares outstanding than it did 5 years ago.
  • IX has a better debt/assets ratio than last year.
IX Yearly Shares OutstandingIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IX Yearly Total Debt VS Total AssetsIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5T 10T 15T

2.2 Solvency

  • Based on the Altman-Z score of 0.66, we must say that IX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of IX (0.66) is comparable to the rest of the industry.
  • The Debt to FCF ratio of IX is 3051.64, which is on the high side as it means it would take IX, 3051.64 years of fcf income to pay off all of its debts.
  • IX has a worse Debt to FCF ratio (3051.64) than 62.00% of its industry peers.
  • IX has a Debt/Equity ratio of 1.47. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.47, IX is not doing good in the industry: 63.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 3051.64
Altman-Z 0.66
ROIC/WACC0.86
WACC3.68%
IX Yearly LT Debt VS Equity VS FCFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T

2.3 Liquidity

  • A Current Ratio of 0.48 indicates that IX may have some problems paying its short term obligations.
  • IX's Current ratio of 0.48 is on the low side compared to the rest of the industry. IX is outperformed by 60.00% of its industry peers.
  • IX has a Quick Ratio of 0.48. This is a bad value and indicates that IX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.43, IX is not doing good in the industry: 61.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.43
IX Yearly Current Assets VS Current LiabilitesIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500B 1T 1.5T 2T 2.5T

3

3. IX Growth Analysis

3.1 Past

  • IX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.80%.
  • Measured over the past years, IX shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.09% on average per year.
  • The Revenue has been growing slightly by 6.76% in the past year.
  • The Revenue has been decreasing by -1.43% on average over the past years.
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%36.63%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%12.46%

3.2 Future

  • Based on estimates for the next years, IX will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.43% on average per year.
  • The Revenue is expected to grow by 7.00% on average over the next years.
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y20.94%
EPS Next 5Y15.43%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y8.11%
Revenue Next 5Y7%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IX Yearly Revenue VS EstimatesIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1T 2T 3T
IX Yearly EPS VS EstimatesIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100 200 300 400

5

4. IX Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.27 indicates a rather expensive valuation of IX.
  • Compared to the rest of the industry, the Price/Earnings ratio of IX is on the same level as its industry peers.
  • IX is valuated rather cheaply when we compare the Price/Earnings ratio to 26.21, which is the current average of the S&P500 Index.
  • IX is valuated correctly with a Price/Forward Earnings ratio of 13.67.
  • IX's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of IX to the average of the S&P500 Index (23.13), we can say IX is valued slightly cheaper.
Industry RankSector Rank
PE 20.27
Fwd PE 13.67
IX Price Earnings VS Forward Price EarningsIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IX is valued a bit cheaper than the industry average as 68.00% of the companies are valued more expensively.
  • 62.00% of the companies in the same industry are cheaper than IX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2444.25
EV/EBITDA 9.69
IX Per share dataIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • IX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • IX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as IX's earnings are expected to grow with 20.94% in the coming years.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y21.71%
EPS Next 3Y20.94%

7

5. IX Dividend Analysis

5.1 Amount

  • IX has a Yearly Dividend Yield of 3.21%. Purely for dividend investing, there may be better candidates out there.
  • IX's Dividend Yield is a higher than the industry average which is at 2.20.
  • IX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.21%

5.2 History

  • On average, the dividend of IX grows each year by 7.63%, which is quite nice.
  • IX has paid a dividend for at least 10 years, which is a reliable track record.
  • IX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)7.63%
Div Incr Years2
Div Non Decr Years2
IX Yearly Dividends per shareIX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

5.3 Sustainability

  • IX pays out 31.18% of its income as dividend. This is a sustainable payout ratio.
  • IX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.18%
EPS Next 2Y21.71%
EPS Next 3Y20.94%
IX Yearly Income VS Free CF VS DividendIX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200B -200B -400B
IX Dividend Payout.IX Dividend Payout, showing the Payout Ratio.IX Dividend Payout.PayoutRetained Earnings

IX Fundamentals: All Metrics, Ratios and Statistics

ORIX - SPONSORED ADR

NYSE:IX (4/6/2026, 8:04:00 PM)

After market: 29.8 0 (0%)

29.8

-0.23 (-0.77%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-09
Earnings (Next)05-11
Inst Owners48.91%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap32.73B
Revenue(TTM)3.13T
Net Income(TTM)439.75B
Analysts77.5
Price Target32.61 (9.43%)
Short Float %0.07%
Short Ratio1.83
Dividend
Industry RankSector Rank
Dividend Yield 3.21%
Yearly Dividend0.75
Dividend Growth(5Y)7.63%
DP31.18%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.45%
EPS NQ rev (1m)-0.12%
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.32%
EPS NY rev (3m)2.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.8%
Revenue NY rev (3m)2.64%
Valuation
Industry RankSector Rank
PE 20.27
Fwd PE 13.67
P/S 1.72
P/FCF 2444.25
P/OCF 3.99
P/B 1.18
P/tB 1.68
EV/EBITDA 9.69
EPS(TTM)1.47
EY4.93%
EPS(NY)2.18
Fwd EY7.31%
FCF(TTM)0.01
FCFY0.04%
OCF(TTM)7.46
OCFY25.04%
SpS17.32
BVpS25.34
TBVpS17.72
PEG (NY)0.79
PEG (5Y)N/A
Graham Number28.95
Profitability
Industry RankSector Rank
ROA 2.5%
ROE 9.9%
ROCE 4.53%
ROIC 3.15%
ROICexc 3.5%
ROICexgc 4.93%
OM 19.97%
PM (TTM) 14.49%
GM 42.41%
FCFM 0.07%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
ROICexc(3y)2.88%
ROICexc(5y)2.73%
ROICexgc(3y)3.79%
ROICexgc(5y)3.66%
ROCE(3y)3.76%
ROCE(5y)3.56%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y0.16%
ROICexc growth 3Y1.76%
ROICexc growth 5Y0.31%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 3051.64
Debt/EBITDA 6.49
Cap/Depr 327.15%
Cap/Sales 43.02%
Interest Coverage 250
Cash Conversion 130.12%
Profit Quality 0.49%
Current Ratio 0.48
Quick Ratio 0.43
Altman-Z 0.66
F-Score7
WACC3.68%
ROIC/WACC0.86
Cap/Depr(3y)325.04%
Cap/Depr(5y)298.28%
Cap/Sales(3y)43.48%
Cap/Sales(5y)39.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%36.63%
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y20.94%
EPS Next 5Y15.43%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%12.46%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y8.11%
Revenue Next 5Y7%
EBIT growth 1Y1.57%
EBIT growth 3Y7.89%
EBIT growth 5Y6.16%
EBIT Next Year12798.5%
EBIT Next 3Y454.57%
EBIT Next 5YN/A
FCF growth 1Y111.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.39%
OCF growth 3Y5.62%
OCF growth 5Y4.52%

ORIX - SPONSORED ADR / IX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ORIX - SPONSORED ADR (IX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IX.


Can you provide the valuation status for ORIX - SPONSORED ADR?

ChartMill assigns a valuation rating of 5 / 10 to ORIX - SPONSORED ADR (IX). This can be considered as Fairly Valued.


How profitable is ORIX - SPONSORED ADR (IX) stock?

ORIX - SPONSORED ADR (IX) has a profitability rating of 6 / 10.


How financially healthy is ORIX - SPONSORED ADR?

The financial health rating of ORIX - SPONSORED ADR (IX) is 2 / 10.


Is the dividend of ORIX - SPONSORED ADR sustainable?

The dividend rating of ORIX - SPONSORED ADR (IX) is 7 / 10 and the dividend payout ratio is 31.18%.